Humulene

Auxly Achieves Key 2021 Target and Launches Exciting Fall Innovation Portfolio

Retrieved on: 
Wednesday, November 10, 2021

TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX - XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, today introduces a fall lineup packed with innovative new products, flavours and formulations designed to delight Canadian cannabis consumers. This new lineup is launching as the Company announces that it has achieved one of its key 2021 objectives by achieving the #5 position among Canadian Licensed Producers.

Key Points: 
  • This new lineup is launching as the Company announces that it has achieved one of its key 2021 objectives by achieving the #5 position among Canadian Licensed Producers.
  • Auxly continues to expand its market share in the Canadian cannabis sector through the Companys strategic growth of its innovative portfolio of branded products.
  • Our iterative process for innovation is rooted in consumer insights, and driven by the tireless execution of product development, sales and marketing.
  • Were thrilled with our continued growth and cant wait to bring more exciting new products to Canadian cannabis consumers.

Introducing Lab Effects, The Sleeping Giant Of The Cannabis Terpene Industry

Retrieved on: 
Thursday, April 18, 2019

"Previously only companies who knew us through word of mouth could access the breadth of our offerings," said Scott Holden, CEO, and Founder of Lab Effects.

Key Points: 
  • "Previously only companies who knew us through word of mouth could access the breadth of our offerings," said Scott Holden, CEO, and Founder of Lab Effects.
  • Humulene, a terpene found in hops, influences the flavor and aroma of beer...and that's just one isolated terpene.
  • According to Lab Effects, the floodgates have opened for product innovation in the cannabis industry and beyond.
  • Lab Effects is the premier and trusted source for botanical profiling, extraction, purification and custom formulation of 100% natural terpenes.

Medical Marijuana, Inc. CEO to Speak at CBD Outlook Conference on Humulus-Derived CBD

Retrieved on: 
Thursday, October 11, 2018

The conference will feature 25 experts, 9 panels and numerous networking events for leaders within the industry.

Key Points: 
  • The conference will feature 25 experts, 9 panels and numerous networking events for leaders within the industry.
  • Dr. Titus' presentation entitled "Humulene (Hops) and CBD Design" will take place at 2 p.m. in Lecture Hall 229.
  • "I am thrilled to speak at this year's CBD Outlook on the exciting topic of Humulus-derived CBD," Titus said.
  • Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop .